SI

Sofinnova Investments Portfolio holdings

AUM $1.47B
This Quarter Return
+77.25%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
AUM
$1.36B
AUM Growth
+$1.36B
Cap. Flow
-$52.8M
Cap. Flow %
-3.89%
Top 10 Hldgs %
67.88%
Holding
77
New
7
Increased
14
Reduced
17
Closed
16
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
QTTB icon
51
Q32 Bio
QTTB
$20.9M
$1.33M 0.1% 64,397 -81,900 -56% -$1.69M
HALO icon
52
Halozyme
HALO
$8.56B
$1.29M 0.09% 72,481 -563,686 -89% -$9.99M
HRTX icon
53
Heron Therapeutics
HRTX
$207M
$1.19M 0.09% 50,500 -53,102 -51% -$1.25M
RYTM icon
54
Rhythm Pharmaceuticals
RYTM
$6.85B
$489K 0.04% +21,319 New +$489K
PDSB icon
55
PDS Biotechnology
PDSB
$57.8M
$378K 0.03% 142,635
AKBA icon
56
Akebia Therapeutics
AKBA
$833M
-1,227,191 Closed -$4.81M
ALGN icon
57
Align Technology
ALGN
$10.3B
-10,000 Closed -$1.81M
ALNY icon
58
Alnylam Pharmaceuticals
ALNY
$58.5B
0
AMGN icon
59
Amgen
AMGN
$155B
-92,300 Closed -$17.9M
BMY icon
60
Bristol-Myers Squibb
BMY
$96B
-478,349 Closed -$24.3M
ONC
61
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
0
VIRX
62
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-1,133,947 Closed -$816K
RETA
63
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-148,669 Closed -$11.9M
ALXN
64
DELISTED
Alexion Pharmaceuticals Inc
ALXN
0
AIMT
65
DELISTED
Aimmune Therapeutics, Inc.
AIMT
-346,770 Closed -$7.26M
PTLA
66
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-59,191 Closed -$1.59M
AGN
67
DELISTED
Allergan plc
AGN
-134,433 Closed -$22.6M
BOLD
68
DELISTED
Audentes Therapeutics, Inc
BOLD
-933,640 Closed -$26.2M
MDCO
69
DELISTED
Medicines Co
MDCO
0
ONCE
70
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-481,270 Closed -$46.7M
CYTK icon
71
Cytokinetics
CYTK
$4.23B
-210,992 Closed -$2.4M
NBIX icon
72
Neurocrine Biosciences
NBIX
$13.8B
-191,679 Closed -$17.3M
PFE icon
73
Pfizer
PFE
$141B
-410,607 Closed -$14.8M
SNDX icon
74
Syndax Pharmaceuticals
SNDX
$1.41B
-243,150 Closed -$1.82M
SVRA icon
75
Savara
SVRA
$567M
-527,318 Closed -$1.4M